| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |